BG Medicine (BGMD) Reports In-Line Q3 EPS

BG Medicine (NASDAQ: BGMD) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $695 thousand versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on BG Medicine (BGMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity to acquire Harte Hanks for $5 per share in cash and stock
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M